Rodman & Renshaw
http://www.rodmanandrenshaw.com/Rodman & Renshaw is an investment bank. The firm provides investment banking services to companies that have significant recurring capital needs along with research, sales, and trading services to institutional investors. The firm focuses on the biotechnology sector and since 2003 has been a leading investment bank to the sector. The firm is also a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
View Older Stories View More Recent Stories
-
Co-Diagnostics CEO Opens up on Goals and Milestones in Interview with Wall Street Analyzer
-
Emerald Health Therapeutics to Present at Rodman & Renshaw 21st Annual Global Investment Conference
-
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019
-
Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019
-
Callitas Health Welcomes Brian D. Keane as Capital Markets and Merger and Acquisitions Consultant
-
NanoViricides CEO Dr. Irach Taraporewala Presents a Letter to Shareholders
-
Matinas BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
NeuroRx to Present at the Annual Rodman & Renshaw Global Investment Conference on Sept 5, 2018
-
Plug Power CFO Paul Middleton to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City on September 6th, 2018
-
Helius Medical Technologies to Participate in the 20th Annual Global Investment Conference Sponsored by Rodman & Renshaw and H.C. Wainwright & Co.
-
Petroteq Energy to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
-
Pershing Gold to Present at Rodman and Renshaw Investment Conference
-
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
-
InspireMD to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York City
-
M2 to Sponsor the 20th Annual Global Investment Conference Hosted by Rodman & Renshaw (H.C. Wainwright & Co.)
-
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Checkpoint Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
CorMedix Inc. to Present at The 20th Annual Rodman & Renshaw Global Investment Conference
-
Reducing Regulatory Fees: Edgar Agents Champions Common Sense Budgeting at 20th Rodman & Renshaw Conference
-
OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Kadmon to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
U.S. Gold Corp. Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
-
Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 20th Annual Global Investment Conference
-
Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
-
Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City
-
WISeKey to Present at the Rodman & Renshaw Annual Global Investment Conference on September 6, in NYC
-
Ur-Energy to Present September 5 at the 20th Annual Rodman & Renshaw Global Investment Conference
-
BLINK CHARGING CO. ANNOUNCES PARTICIPATION AT THE 20TH ANNUAL RODMAN & RENSHAW GLOBAL INVESTMENT CONFERENCE IN NEW YORK CITY SEPTEMBER 4-6, 2018
-
Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City
-
AzurRx BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 5th
-
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
-
Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference
-
NEMUS Bioscience to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Emerald Health Pharmaceuticals to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
Emerald Health Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
DPW Holdings, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
General Moly Presents at Rodman & Renshaw Investment Conference
-
Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
-
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
-
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
-
Dawson James Securities Announces Addition of Veteran Wall Street Investment Banker Michael Rindos in New York
-
Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences
-
Oryzon Genomics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference and at the 17th Annual Biotech in Europe Forum
-
ESSA Pharma (EPIX) Reports Results from Phase 1 Trial of EPI-506 for Treatment of mCRPC; Provides Update on Clinical and Strategic Plans
-
TearLab to Present at the 19th Annual Rodman and Renshaw Global Investment Conference

